ABT (Abbott Laboratories Inc.) Margin reged

Abbott Laboratories revenue stability is based on excellent diversification across diagnostics, nutrition, and pharmaceuticals. The annual gross margin demonstrates the business's resilience to costs, while 52.30 represents the latest level. Growth is driven by FreeStyle Libre systems and elective surgeries, while the expansion of sales markets is supported by a global increase in chronic pathologies and demand for home tests.
Rincian analitis lan laporan data perusahaan Abbott Corp. (ABT)

Gross margin is calculated as the difference between total revenue and direct production costs, expressed as a percentage of revenue. This indicator measures cost management efficiency and the business's pricing power in the market. For Abbott Laboratories (ABT), the integration of niche technologies and the expansion of distribution allow for cost optimization, maintaining high profitability. By analyzing the current gross margin level, an investor can assess the sustainability of the company's operating model.